Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Currently there is no conclusive test that exists to predict who will develop Alzheimer’s.  Now, research from The University of Texas, University of Illinois, UT Southwestern and John Hopkins University is attempting to identify a potential biomarker that could offer a more complete picture … Continue reading Non-invasive neuroimaging marker shows great potential for Alzheimer’s risk detection.